Discover
TVRD
Tvardi Therapeutics, Inc.
1.63
2 x 1.19
2 x 2.04
bid
ask
+
0.01
0.62%
2 @ 07:30 PM
1.61 -0.02 (1.18%)
| Ytd | -62.09% | |
| 1y | -95.79% |
1.59
day range
1.66
1.50
52 week range
42.98
| Open | 1.63 | Prev Close | 1.62 | Low | 1.59 | High | 1.66 | Mkt Cap | 21.74M |
| Vol | 121.59K | Avg Vol | 2.38M | EPS | -2.87 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.32 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 2.17 | 200-d Avg | 3.24 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 6.63M | ||
| Research and Development Expense | 4.00M | ||
| Selling, General and Administrative Expense | 2.63M | ||
| Operating Income | -6.63M | ||
| Net Income | -6.46M | ||
| Net Income Common Stock | -6.46M | ||
| Net Income Common Stock (USD) | -6.46M | ||
| Consolidated Income | -6.46M | ||
| Earnings per Basic Share | -0.69 | ||
| Earnings per Basic Share (USD) | -0.69 | ||
| Earnings per Diluted Share | -0.69 | ||
| Earning Before Interest & Taxes (EBIT) | -6.46M | ||
| Earning Before Interest & Taxes (USD) | -6.46M | ||
| Weighted Average Shares | 9.38M | ||
| Weighted Average Shares Diluted | 9.38M | ||
| Balance Sheet | |||
| Cash and Equivalents | 15.77M | ||
| Cash and Equivalents (USD) | 15.77M | ||
| Current Assets | 17.07M | ||
| Property, Plant & Equipment Net | 140.00K | ||
| Total Assets | 17.52M | ||
| Debt Current | 123.00K | ||
| Total Debt | 145.00K | ||
| Current Liabilities | 9.11M | ||
| Debt Non-Current | 22.00K | ||
| Total Liabilities | 9.14M | ||
| Accumulated Retained Earnings (Deficit) | -123.71M | ||
| Shareholders Equity | 8.38M | ||
| Shareholders Equity (USD) | 8.38M | ||
| Assets Non-Current | 448.00K | ||
| Total Debt (USD) | 145.00K | ||
| Goodwill and Intangible Assets | 291.00K | ||
| Liabilities Non-Current | 22.00K | ||
| Trade and Non-Trade Payables | 4.64M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 43.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.09M | ||
| Net Cash Flow from Investing | 5.14M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 5.14M | ||
| Net Cash Flow from Operations | -9.23M | ||
| Share Based Compensation | 335.00K | ||